Publicaciones en colaboración con investigadores/as de Universidad Maimónides (10)

2023

  1. ROR2 promotes epithelial-mesenchymal transition by hyperactivating ERK in melanoma

    Journal of Cell Communication and Signaling, Vol. 17, Núm. 1, pp. 75-88

2022

  1. Bcl-2-like protein-10 increases aggressive features of melanoma cells

    Exploration of Targeted Anti-tumor Therapy, Vol. 3, Núm. 1, pp. 11-26

  2. Bioinformatic analysis identifies epidermal development genes that contribute to melanoma progression

    Medical Oncology, Vol. 39, Núm. 10

  3. Cellular and molecular mechanisms implicated in the dual role of ROR2 in cancer

    Critical Reviews in Oncology/Hematology, Vol. 170

  4. Correction to: ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation (Cellular & Molecular Biology Letters, (2022), 27, 1, (23), 10.1186/s11658-022-00327-7)

    Cellular and Molecular Biology Letters

  5. ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation

    Cellular and Molecular Biology Letters, Vol. 27, Núm. 1

2021

  1. BCL2l10 is overexpressed in melanoma downstream of STAT3 and promotes cisplatin and ABT-737 resistance

    Cancers, Vol. 13, Núm. 1, pp. 1-22

  2. ROR2 has a protective role in melanoma by inhibiting Akt activity, cell-cycle progression, and proliferation

    Journal of Biomedical Science, Vol. 28, Núm. 1

2019

  1. An autocrine Wnt5a loop promotes NF-κB pathway activation and cytokine/chemokine secretion in melanoma

    Cells, Vol. 8, Núm. 9

  2. STAT3 enhances the constitutive activity of AGC kinases in melanoma by transactivating PDK1

    Cell and Bioscience, Vol. 9, Núm. 1